These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 943563)

  • 1. Tumor-specific immunogenicity induced by chemical modification.
    Eggers AE
    J Natl Cancer Inst; 1976 Apr; 56(4):869-70. PubMed ID: 943563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical enhancement of tumor immunogenicity.
    Eggers AE; Hibbard CA; Civin CI; Wunderlich JR
    J Immunol; 1980 Oct; 125(4):1737-44. PubMed ID: 6967915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro.
    Kall MA; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5086-9. PubMed ID: 1082135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS; Bartlett GL
    J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune response to an allogeneic progressively growing solid tumor.
    Eggers AE
    Cancer Res; 1976 Jun; 36(6):2085-9. PubMed ID: 773534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cytotoxicity in vitro of lymphocytes sensitized in culture against tumor cells.
    Schechter B; Treves AJ; Feldman M
    J Natl Cancer Inst; 1976 May; 56(5):975-9. PubMed ID: 994207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1978; 24(2):118-27. PubMed ID: 658547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA; Hellström I
    J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
    Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
    J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to MCA-induced rat sarcomas: analysis of in vivo and in vitro results.
    Harmon RC; Clark EA; Reddy AL; Hildemann WH; Mullen Y
    Int J Cancer; 1977 Nov; 20(5):748-58. PubMed ID: 924692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of x-irradiation of recipients on in vivo neutralization of syngeneic tumors by spleen cells nonspecificially immunized with allogeneic tumors.
    Nakayama M; Sendo F; Gotohda E; Kobayashi H
    Gan; 1977 Aug; 68(4):509-12. PubMed ID: 80344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.
    Mazumder A; Rosenstein M; Rosenberg SA
    Cancer Res; 1983 Dec; 43(12 Pt 1):5729-34. PubMed ID: 6640524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of covalently bound cord factor analog to increase tumor immunogenicity.
    Eggers AE; Tarmin L; Ginsburg S
    J Biol Response Mod; 1984 Aug; 3(4):413-22. PubMed ID: 6332882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.